CLSA Maintains Outperform Rating for MGM CHINA (02282.HK) Following Strong 4Q25 Property EBITDA Results
Financial Performance: MGM China reported a 29% year-over-year increase in 4Q25 property EBITDA to $2.753 billion, surpassing market expectations due to a high VIP win rate at MGM Cotai.
Market Share and Margins: The company's GGR market share rose by 0.6 percentage points to 16.3%, with property EBITDA margins increasing by 0.2 percentage points to 26.8%, indicating effective expense management.
Broker Rating and Target Price: CLSA maintained an "Outperform" rating for MGM China, setting a target price of $20.9, based on a forecasted EV/EBITDA of 7.2x for 2026.
Short Selling Activity: MGM China experienced short selling of $13.70 million, with a short selling ratio of 9.506%, reflecting market sentiment.
Trade with 70% Backtested Accuracy
Analyst Views on 02282
About the author
CICC Reports MGM CHINA (02282.HK) Exceeds 4Q25 Adjusted EBITDA Expectations, Maintains Outperform Rating
MGM China's Financial Performance: MGM China reported a net revenue of RMB9.617 billion in 4Q25, achieving 169% of the revenue from the same period in 2019, with adjusted EBITDA of RMB2.753 billion surpassing expectations.
High-End Business Growth: The strong performance was attributed to the high-end business segment, with MGM Cotai and MGM Macau's total GGR recovering to 214% and 104% of 2019 levels, respectively.
Broker Recommendations: CICC maintained its EBITDA forecasts for MGM China for 2026 and 2027, keeping an Outperform rating and a target price of HKD16.1.
Citi's Position: Citi reiterated a Buy rating on MGM China with a target price of HKD18.25, reflecting confidence in the company's ongoing recovery and performance.
Macquarie Adjusts MGM China’s Target Price to HKD21.6, Anticipates Hotel Room Enhancements to Increase Market Share
MGM CHINA's Financial Performance: MGM CHINA's 4Q25 results surpassed expectations, with net revenue rising 21% YoY to HKD9.62 billion, and GGR also increasing by 21% YoY to HKD10.5 billion.
Future Plans and Upgrades: The company plans to upgrade its hotel rooms this year, aiming to enhance its high-end appeal and increase market share.
Analyst Rating and Target Price: Macquarie has raised its target price for MGM CHINA by 1% to HKD21.6, maintaining an "Outperform" rating.
Short Selling Data: As of February 9, 2026, MGM CHINA has a short selling amount of $3.71 million, with a ratio of 5.019%.
UBS Assigns Buy Rating to MGM CHINA; Remains Positive on CNY Performance
Financial Performance: MGM CHINA's 4Q25 adjusted property EBITDA increased by 29% year-over-year to USD353 million, aligning with market expectations after adjustments for VIP room win rates.
Market Outlook: The company's management remains optimistic about the competitive environment and anticipates strong performance during the Chinese New Year holiday due to positive booking trends.
Stock Rating: UBS maintains a target price of HKD18.5 for MGM CHINA, with a "Buy" rating reflecting confidence in the company's future performance.
Short Selling Activity: The short selling for MGM CHINA is reported at $12.65 million, with a ratio of 10.407%, indicating a notable level of market speculation.
Citi Maintains Buy Rating on MGM CHINA (02282.HK) with Target Price of HKD18.25
Financial Performance: MGM CHINA reported a record high quarterly EBITDA of RMB2.753 billion in 4Q25, with an annual EBITDA exceeding RMB10 billion and an improved EBITDA margin of 28.6%.
Market Outlook: Management noted strong booking trends and a long waiting list for premium hotel products ahead of the Lunar New Year, indicating no signs of a pre-holiday slowdown.
CLSA Maintains Outperform Rating for MGM CHINA (02282.HK) Following Strong 4Q25 Property EBITDA Results
Financial Performance: MGM China reported a 29% year-over-year increase in 4Q25 property EBITDA to $2.753 billion, surpassing market expectations due to a high VIP win rate at MGM Cotai.
Market Share and Margins: The company's GGR market share rose by 0.6 percentage points to 16.3%, with property EBITDA margins increasing by 0.2 percentage points to 26.8%, indicating effective expense management.
Broker Rating and Target Price: CLSA maintained an "Outperform" rating for MGM China, setting a target price of $20.9, based on a forecasted EV/EBITDA of 7.2x for 2026.
Short Selling Activity: MGM China experienced short selling of $13.70 million, with a short selling ratio of 9.506%, reflecting market sentiment.
MGM China Reports Over 10% Year-on-Year Increase in 2025 Adjusted EBITDA, Reaching Record $10.005 Billion
Stock Performance: MGM CHINA's stock decreased by 3.679%, with a short selling amount of $13.70 million and a ratio of 9.506%.
Revenue Growth: MGM Resorts International reported that MGM CHINA's total revenue for the year ending December 2025 rose by 10.8% year-over-year, reaching $34.787 billion.
CICC Reports MGM CHINA (02282.HK) Exceeds 4Q25 Adjusted EBITDA Expectations, Maintains Outperform Rating
MGM China's Financial Performance: MGM China reported a net revenue of RMB9.617 billion in 4Q25, achieving 169% of the revenue from the same period in 2019, with adjusted EBITDA of RMB2.753 billion surpassing expectations.
High-End Business Growth: The strong performance was attributed to the high-end business segment, with MGM Cotai and MGM Macau's total GGR recovering to 214% and 104% of 2019 levels, respectively.
Broker Recommendations: CICC maintained its EBITDA forecasts for MGM China for 2026 and 2027, keeping an Outperform rating and a target price of HKD16.1.
Citi's Position: Citi reiterated a Buy rating on MGM China with a target price of HKD18.25, reflecting confidence in the company's ongoing recovery and performance.
Macquarie Adjusts MGM China’s Target Price to HKD21.6, Anticipates Hotel Room Enhancements to Increase Market Share
MGM CHINA's Financial Performance: MGM CHINA's 4Q25 results surpassed expectations, with net revenue rising 21% YoY to HKD9.62 billion, and GGR also increasing by 21% YoY to HKD10.5 billion.
Future Plans and Upgrades: The company plans to upgrade its hotel rooms this year, aiming to enhance its high-end appeal and increase market share.
Analyst Rating and Target Price: Macquarie has raised its target price for MGM CHINA by 1% to HKD21.6, maintaining an "Outperform" rating.
Short Selling Data: As of February 9, 2026, MGM CHINA has a short selling amount of $3.71 million, with a ratio of 5.019%.
UBS Assigns Buy Rating to MGM CHINA; Remains Positive on CNY Performance
Financial Performance: MGM CHINA's 4Q25 adjusted property EBITDA increased by 29% year-over-year to USD353 million, aligning with market expectations after adjustments for VIP room win rates.
Market Outlook: The company's management remains optimistic about the competitive environment and anticipates strong performance during the Chinese New Year holiday due to positive booking trends.
Stock Rating: UBS maintains a target price of HKD18.5 for MGM CHINA, with a "Buy" rating reflecting confidence in the company's future performance.
Short Selling Activity: The short selling for MGM CHINA is reported at $12.65 million, with a ratio of 10.407%, indicating a notable level of market speculation.
Citi Maintains Buy Rating on MGM CHINA (02282.HK) with Target Price of HKD18.25
Financial Performance: MGM CHINA reported a record high quarterly EBITDA of RMB2.753 billion in 4Q25, with an annual EBITDA exceeding RMB10 billion and an improved EBITDA margin of 28.6%.
Market Outlook: Management noted strong booking trends and a long waiting list for premium hotel products ahead of the Lunar New Year, indicating no signs of a pre-holiday slowdown.
CLSA Maintains Outperform Rating for MGM CHINA (02282.HK) Following Strong 4Q25 Property EBITDA Results
Financial Performance: MGM China reported a 29% year-over-year increase in 4Q25 property EBITDA to $2.753 billion, surpassing market expectations due to a high VIP win rate at MGM Cotai.
Market Share and Margins: The company's GGR market share rose by 0.6 percentage points to 16.3%, with property EBITDA margins increasing by 0.2 percentage points to 26.8%, indicating effective expense management.
Broker Rating and Target Price: CLSA maintained an "Outperform" rating for MGM China, setting a target price of $20.9, based on a forecasted EV/EBITDA of 7.2x for 2026.
Short Selling Activity: MGM China experienced short selling of $13.70 million, with a short selling ratio of 9.506%, reflecting market sentiment.
MGM China Reports Over 10% Year-on-Year Increase in 2025 Adjusted EBITDA, Reaching Record $10.005 Billion
Stock Performance: MGM CHINA's stock decreased by 3.679%, with a short selling amount of $13.70 million and a ratio of 9.506%.
Revenue Growth: MGM Resorts International reported that MGM CHINA's total revenue for the year ending December 2025 rose by 10.8% year-over-year, reaching $34.787 billion.
